ORBIMED ADVISORS LLC

Q4 2018 13F Holdings Report, Stock Holdings

Signature - Title
Sven H. Borho - Member
Location
New York, NY
Holdings as of
31 Dec 2018
Value $
$5.36B
Num holdings
125
Filing time
14 Feb 2019, 16:35:05 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included TCDAQ, ASND, BIIB, CELG, and BSX.
Previous filing
Q3 2018 - 14 Nov 2018
Next filing
Q1 2019 - 15 May 2019
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2018 Q4 compared to 2018 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Sven H. Borho Member New York, New York 14 Feb 2019

Other Included Managers (1):

Num Name Location File Number
1 ORBIMED CAPITAL LLC New York, NY 028-10410